US reclassifies some cannabis products as less dangerous
Acting Attorney General Todd Blanche on Thursday announced that cannabis products covered by the Food and Drug Administration or licensed for medical use by states will be moved from Schedule I to Schedule III under federal law, a step the Justice Department says will expand research and patient access. The change affects FDA-approved or state-authorized … Read more